Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong

Infectious Diseases

Volumn 47, Issue 5, 2015, Pages 283-288

  Pau, Carrie K Y ^a   Ma, Florence F T ^a   Ip, Margaret ^a   You, Joyce H S ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Bacteraemia; Cost; Hong Kong; Klebsiella pneumoniae; Mortality

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; IMMUNOSUPPRESSIVE AGENT; PIPERACILLIN PLUS TAZOBACTAM; BETA LACTAMASE;

ABDOMINAL INFECTION; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ASSESSMENT OF HUMANS; BACTEREMIA; BLOOD CULTURE; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HEALTH CARE COST; HEALTHCARE ASSOCIATED INFECTION; HONG KONG; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PITT BACTEREMIA SCORE; PNEUMONIA; VERY ELDERLY; COMPARATIVE STUDY; CROSS INFECTION; EPIDEMIOLOGY; INFECTION CONTROL; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; BACTEREMIA; BETA-LACTAMASES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HONG KONG; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84983098178     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365548.2014.985710     Document Type: Article

References (24)

1. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002 ; 8 : 160-6 .
2. Meatherall BL, Gregson D, Ross T, Pitout PDD, Laupland KB. Incidence, risk factors and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009 ; 122 : 866-73 .
3. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, et al. Bloodstream infections caused by extended-spectrum- β -lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006 ; 50 : 498-504 .
4. Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006 ; 21 : 816-22 .
5. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacillin isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART. J Antimicrob Chemother 2006 ; 58 : 205-10 .
6. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003 ; 37 : 745-51 .
7. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP Jr, et al. Asystematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007 ; 45 : 329-37 .
8. Paterson DL, Ko WC, Gottberg AV, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: implication of extended-spectrum β -lactamase production in nosocomial infections. Ann Intern Med 2004 ; 140 : 26-32 .
9. Government of Hong Kong SAR. Website: http://www.gov.hk (accessed 22 March 2014).
10. Yang JY, Ye LY, Wang WW, Luo YP, Zhang YJ, Han L. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int J Antimicrob Agents 2011 ; 38 : 348-51 .
11. Kim DM, Park WB, Lee KD, Kim HB, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004 ; 25 : 860-7 .
12. Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for communityacquired infection. Arch Intern Med 2002 ; 162 : 1012-17 .
13. Liao CH, Lai CC, Hsu MS, Huang YT, Chu FY, Hsu HS, et al. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study. Clin Microbiol Infect 2009 ; 15 : 1119-25 .
14. Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Bobadilla- del-Valle JM, Silva-Sánchez J, Garza-Ramos U, et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae: a case control study. Int J Infect Dis 2008 ; 12 : 653-9 .
15. Kim BN, Woo JH, Kim MN, Ryu J, Kim Y S. Clinical implications of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002 ; 52 : 99-106 .
16. Kang CI, Chung DR, Ko KS, Peck KR, Song JH ; Korean Network for Study of Infectious Diseases. Risk factors for infection and treatment outcome of extendedspectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 2012 ; 91 : 115-21 .
17. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006 ; 50 : 1257-62 .
18. Cosgrove SE, Kaye KS, Eliopoulos GM, Carmeli Y. Health and economic outcomes of the emergence of thirdgeneration cephalosporin resistance in Enterobacter species. Arch Intern Med 2002 ; 162 : 185-90 .
19. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007 ; 20 : 391-6 .
20. El-Solh AA, Peter M, Alfarah Z, Akinnusi ME, Alabbas A, Pineda LA. Antibiotic prescription patterns in hospitalized patients with nursing home-acquired pneumonia. J Hosp Med 2010 ; 5 : E5-E10 .
21. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012 ; 38 : 1930-45 .
22. You JH, Chow TC, Yeung AW, Lee N, Ip M. Acinetobacter baumannii bacteraemia in Hong Kong. J Hosp Infect 2010 ; 75 : 81 .
23. You JH, Mok SS, Chang CC, Lee N, Ip M. Bacteremia with extended-spectrum β-lactamases-producing Escherichia coli in Hong Kong. Int J Antimicrob Agents 2009 ; 34 : 615-16 .
24. Blot SI, Vandewoude KH, Colardyn FA. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis 2002 ; 21 : 471-3 .